Subscribe
Retroperitoneal Lymph Node Dissection In Patients With High Risk Testicular Cancer 
Medical News Today | Mon, Aug 3
UroToday.com - We performed a retrospective review of retroperitoneal lymph node dissection (RPLND) patients with high risk features (30% embryonal carcinoma, with or without lymphovascular invasion) and compared primary (P-RPLND) versus post-chemotherapy (PC-RPLND) patient...
Try These Related Topics
Related News
Thrombosis of abdominal aorta during cisplatin-based chemotherapy of ... - 7thSpace Interactive
Lewis Bees wants to concentrate on rugby after battle with cancer
Denver Councilman Paul Lopez reveals treatment for cancer
Chris Horsman blows whistle on great divide between players and officials
Hartson thanks fans after positive news on cancer
Cisplatin-based chemotherapy linked to severe side effects in long-term ...
Top Bloggers
| 1 | Simple Thoughts - J... |
| 2 | Men's News Daily |
| 3 | dBTechno |
| 4 | Market Wire |
| 5 | Nursing Times |
| 6 | HemOncToday |
| 7 | Sacramento News & R... |
| 8 | Adrants |
| 9 | PHG Foundation |
Photo Gallery
More meds in the state-subsidized basket
The committee recommended that the state pay for PET-CT scans to diagnose possibly metastacized testicular cancer for 13 patients a year. ...
Wed, Dec 23 | from Ha'aretz
